Positive Quality Interventions Highlight Appropriate Drug Therapy

PQIs promote higher quality patient care through increased speed to therapy, reduced cost and hospitalization and by improving persistence and adherence.

The treatment and management of oncology patients on oral drug therapy is continually changing and evolving. Professionals at in-office dispensing practices are in a unique position to ensure proper treatment, increase compliance and maximize outcomes. Positive Quality Interventions (PQIs), an NCODA Quality Standard, are designed to operationalize and standardize those practices to achieve these positive clinical outcomes.

SEARCH PQIs

Abemaciclib Appropriate Patient Identification

Written by: Jan Montgomery, PharmD, South Carolina Oncology Associates and Jacob Dygert, South University School of Pharmacy

Positive Quality Interventions

Positive Quality Interventions Highlight Appropriate Drug Therapy

SEARCH PQIs

PQI CORPORATE SPONSORS

Neal Dave, PharmD, Chair – Texas Oncology, TX

Julianne Orr, PharmD, BCOP, Chair – Indiana University Health, Simon Cancer Center, IN

Howard Cohen, BS, PharmD, MS, FASHP, Chair-Elect – Smilow Cancer Hospital/Yale New Haven Health, CT

Chara Reid-Reed, PharmD – Dupage Medical Group, IL

Darrell Willyard, PharmD – OCSRI, OK

Gina Wertz, PharmD – Nebraska Hematology Oncology, NE

Jen Hasiak O’Doherty, PharmD – Hematology & Oncology Consultants Pharmacy

Jody Agena, PharmD, MBA, BCOP – Virginia Cancer Specialists, VA

Kirollos Hanna, PharmD, BCPS, BCOP – University of Minnesota Medical Center & Mayo Clinic, MN

Lawrence Garbo, MD – New York Oncology Hematology, NY

Marie Sirek, PharmD – Billings Clinic, MT

Margaret McGuinness, PharmD, BCOP – Compass Oncology, OR

Natasha Heimbigner, PharmD – Summit Cancer Centers, WA

Yen Nguyen, PharmD – Oncology Consultants, PA, TX